Results 181 to 190 of about 122,680 (303)

Transitioning from deceptive to nondeceptive placebo treatment to reduce pathological skin-picking. [PDF]

Discov Ment Health
Schienle A, Wilhelm J, Tanzmeister S.
europepmc   +1 more source

Learning Pain in Context: Response-Conditioned Placebo Analgesia and Nocebo Hyperalgesia in Male Rats with Chronic Neuropathic Pain

, 2022
Damien C. Boorman, Kevin A. Keay
openalex   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double‐blind, randomised, placebo‐controlled, multi‐centre trial

, 2020
Mads Langager Larsen, Lone Krebs, Gija Rackauskaite, Christina Engel Hoei‐Hansen, Gorm Greisen   +4 more
openalex   +2 more sources

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

Has the time come to stop using control groups in trials of psychosocial interventions? [PDF]

World Psychiatry
Cuijpers P.
europepmc   +1 more source

S7A:4 Reduction of systemic lupus flares by atacicept in a randomised, placebo-controlled, phase iib study (address ii) and its extension study [PDF]

, 2018
DJ Wallace, David Isenberg, Amy Kao, Cristina Vazquez‐Mateo, Patricia Fleuranceau-Morel, Peter Chang, JT Merril   +6 more
openalex   +1 more source

Unraveling the mystery of placebo effect in research and practice: An update. [PDF]

Perspect Clin Res
Mishra P, Bhargava S.
europepmc   +1 more source

A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica

, 1981
B. N. Statham, A.Y. Finlay, R. Marks
openalex   +2 more sources

Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis

Arthritis &Rheumatology, EarlyView.
Objective Placebo effects are a significant challenge in the conduct of clinical trials. We explored how global recruitment patterns influence the extent of placebo responses in randomized controlled trials of psoriatic arthritis and plaque psoriasis.
Andreas Kerschbaumer, Marlene Steiner, Suzanne Khalili, Azad Shehab, Alexander Jordanov, Brigitte Wildner, Magdalena Maad, Josef S. Smolen, Daniel Aletaha   +8 more
wiley   +1 more source